The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Serial circulating tumor DNA samples from patients with metastatic breast cancer and BRCA1/2 mutations.
 
Katharine Collier
Research Funding - Conquer Cancer Foundation
 
David Tallman
No Relationships to Disclose
 
Zachary Weber
No Relationships to Disclose
 
Marcy Haynam
No Relationships to Disclose
 
Elizabeth J. Adams
No Relationships to Disclose
 
Janet Jenison
No Relationships to Disclose
 
Sarah Asad
No Relationships to Disclose
 
Maryam B. Lustberg
Honoraria - bioTheranostics; Novartis
Consulting or Advisory Role - Disarm Therapeutics; PledPharma
Other Relationship - Cynosure/Hologic
 
Mathew Amprayil Cherian
No Relationships to Disclose
 
Bhuvaneswari Ramaswamy
Consulting or Advisory Role - Eisai
 
Sagar D. Sardesai
Honoraria - bioTheranostics; Immunomedics; Novartis
Consulting or Advisory Role - Novartis
Speakers' Bureau - Immunomedics
Travel, Accommodations, Expenses - Novartis
 
Nicole Olivia Williams
No Relationships to Disclose
 
Robert Wesolowski
Consulting or Advisory Role - Roche
Speakers' Bureau - ONCOLIVE
Travel, Accommodations, Expenses - Roche
 
Jeffrey Bryan VanDeusen
No Relationships to Disclose
 
Margaret Elena Gatti-Mays
No Relationships to Disclose
 
Ashley Pariser
No Relationships to Disclose
 
Amir Mortazavi
Honoraria - Motive Medical Intelligence
Consulting or Advisory Role - Debiopharm Group; Pfizer; Seagen
Research Funding - Acerta Pharma (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Debiopharm Group (Inst); Debiopharm Group (Inst); Genentech/Roche (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Roche (Inst); Seagen (Inst)
 
Daniel G. Stover
No Relationships to Disclose